发明公开
- 专利标题： PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
- 专利标题（中）： 非饱和含氮杂环含氮化合物
-
申请号： EP13825784.5申请日： 2013-07-29
-
公开(公告)号： EP2881384A1公开(公告)日： 2015-06-10
- 发明人: TAKAYAMA, Tetsuo , SHIBATA, Tsuyoshi , SHIOZAWA, Fumiyasu , KAWABE, Kenichi , SHIMIZU, Yuki , HAMADA, Makoto , HIRATATE, Akira , TAKAHASHI, Masato , USHIYAMA, Fumihito , OI, Takahiro , SHIRASAKI, Yoshihisa , MATSUDA, Daisuke , KOIZUMI, Chie , KATO, Sota
- 申请人： Taisho Pharmaceutical Co., Ltd.
- 申请人地址： 24-1, Takada 3-chome Toshima-ku Tokyo 170-8633 JP
- 专利权人： Taisho Pharmaceutical Co., Ltd.
- 当前专利权人： Taisho Pharmaceutical Co., Ltd.
- 当前专利权人地址： 24-1, Takada 3-chome Toshima-ku Tokyo 170-8633 JP
- 代理机构： Hoffmann Eitle
- 优先权： JP2012168828 20120730
- 国际公布： WO2014021281 20140206
- 主分类号： C07D207/36
- IPC分类号： C07D207/36 ; A61K31/4015 ; A61K31/4412 ; A61K31/4418 ; A61K31/443 ; A61K31/4436 ; A61K31/4439 ; A61K31/444 ; A61K31/4545 ; A61K31/4704 ; A61K31/4709 ; A61K31/496 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61K31/5377 ; A61K31/55 ; A61P7/06 ; A61P43/00
摘要：
There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I'):
(in the above-mentioned general formula (I'),
W, Y, R 2 , R 3 , R 4 , and Y 4 are as described hereinabove), or pharmaceutically acceptable salts thereof.
(in the above-mentioned general formula (I'),
W, Y, R 2 , R 3 , R 4 , and Y 4 are as described hereinabove), or pharmaceutically acceptable salts thereof.
公开/授权文献
信息查询
